Jacobs Levy Equity Management
CL icon

Jacobs Levy Equity Management’s Colgate-Palmolive CL Stock Holding History

Jacobs Levy Equity Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
124,308
+56,157
+82% +$5.01M 0.04% 297
2025
Q4 		$5.39M Sell
68,151
-39,253
-37% -$3.08M 0.02% 391
2025
Q3 		$8.59M Buy
107,404
+73,611
+218% +$6.28M 0.03% 326
2025
Q2 		$3.07M Sell
33,793
-174,563
-84% -$15.9M 0.01% 548
2025
Q1 		$19.5M Sell
208,356
-395,697
-66% -$35.4M 0.08% 227
2024
Q4 		$54.9M Sell
604,053
-173,801
-22% -$16.6M 0.19% 124
2024
Q3 		$80.7M Buy
777,854
+697,168
+864% +$71.1M 0.31% 83
2024
Q2 		$7.83M Buy
+80,686
New +$7.44M 0.03% 369
2020
Q1 		– Sell
-19,950
Closed -$1.37M – 1013
2019
Q4 		$1.37M Sell
19,950
-28,580
-59% -$1.95M 0.01% 621
2019
Q3 		$3.57M Sell
48,530
-28,570
-37% -$2.07M 0.04% 395
2019
Q2 		$5.53M Sell
77,100
-4,810
-6% -$341K 0.08% 323
2019
Q1 		$5.61M Buy
81,910
+26,600
+48% +$1.72M 0.08% 308
2018
Q4 		$3.29M Sell
55,310
-50,010
-47% -$3.13M 0.06% 348
2018
Q3 		$7.05M Sell
105,320
-117,960
-53% -$7.86M 0.1% 236
2018
Q2 		$14.5M Sell
223,280
-32,770
-13% -$2.14M 0.23% 130
2018
Q1 		$18.4M Buy
256,050
+230,910
+918% +$16.6M 0.31% 106
2017
Q4 		$1.9M Buy
25,140
+14,580
+138% +$1.06M 0.03% 472
2017
Q3 		$769K Buy
+10,560
New +$761K 0.01% 633
2017
Q1 		– Sell
-7,770
Closed -$508K – 925
2016
Q4 		$508K Buy
7,770
+1,470
+23% +$101K 0.01% 678
2016
Q3 		$467K Sell
6,300
-830
-12% -$61.4K 0.01% 726
2016
Q2 		$522K Buy
+7,130
New +$508K 0.01% 740
2014
Q3 		– Sell
-24,750
Closed -$1.69M – 833
2014
Q2 		$1.69M Sell
24,750
-260
-1% -$17.4K 0.03% 427
2014
Q1 		$1.62M Sell
25,010
-248,040
-91% -$15.6M 0.03% 437
2013
Q4 		$17.8M Sell
273,050
-84
-0% -$5.38K 0.27% 117
2013
Q3 		$16.2M Sell
273,134
-501,084
-65% -$29.7M 0.27% 121
2013
Q2 		$44.4M Buy
+774,218
New +$46M 0.78% 18

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jacobs Levy Equity Management's CL Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Colgate-Palmolive (CL) stake by 82% in Q1 2026, buying an estimated $5.01M and bringing the position to 124,308 shares worth $10.6M. The position accounts for 0.04% of the portfolio, ranked #297.

Jacobs Levy Equity Management first reported a position in CL in Q2 2013 and has held it in 26 quarters since. The position peaked at $80.7M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Jacobs Levy Equity Management held 124,308 shares of Colgate-Palmolive worth $10.6M as of Q1 2026.
  • Jacobs Levy Equity Management bought 56,157 Colgate-Palmolive shares in Q1 2026, an estimated $5.01M.
  • Colgate-Palmolive made up 0.04% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #297 holding.
  • Jacobs Levy Equity Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
  • Jacobs Levy Equity Management's Colgate-Palmolive position peaked at $80.7M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.